RARA CRAFT DATABASE for FDA Medical Devices
510(k)K172920

FDA DEVICE FACTS

3D APT

Philips Medical Systems Nederland B.V.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 22, 2018PRODUCT CODELNH

Indications for use

3D Amide Proton Transfer weighted MRI (3D APT) is a software feature intended for use on Ingenia 3.0T (70cm) and Ingenia 3.0T CX (60cm) MR Systems. It’s indicated for use in magnetic resonance imaging of the brain.

Amide Proton Transfer weighted imaging (3D APT) is a software option intended for use on Ingenia 3.0T and Ingenia 3.0T CX MR Systems. 3D APT is indicated for use in magnetic resonance imaging of the brain. 3D APT consists of an acquisition and reconstruction technique employing frequency-selective magnetization transfer effects to derive images reflecting the spatial distribution of amide protons, and thereby protein density. 3D APT images may assist a trained physician in diagnosis and therapy planning. APTW can be combined with multi-coil acceleration approaches (SENSE). Design Features and Fundamental Scientific Technology: 3D Amide Proton Transfer (3D APT) is an MR imaging technology where saturation of the water signal using the magnetization transfer effect generates the contrast. Protons bound to macromolecules, specifically amide protons, exchange with the free water pool. Selective narrow-band excitation at the amide proton resonance frequency is used to detect signal differences exclusively associated with the amide protons. This is achieved by a controlled, frequency-selective RF irradiation to saturate protons resonating at +3.5 ppm (the amide proton resonance frequency), and comparing the resulting signal level to that observed when irradiating at −3.5 ppm. The feature consists of:

• Frequency selective saturation RF pulses (1-2 s duration), alternating between the two channels of the MultiTransmit RF system, at multiple offset frequencies

• 3D DIXON TSE readout

• Signal difference calculation between +3.5 ppm and −3.5 ppm to derive the APTw image

• B0 inhomogeneity correction embedded into the APTw calculation

• Color scale (rainbow) to display APTw signals between −5% and +5%. Philips Medical Systems Nederland B.V. Magnetic Resonance Imaging 3D APT K172920

Premarket Notification [510(k)] Submission Philips Medical Systems Nederland B.V. 3D APT K172920 Summary of Non-Clinical

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026